Standardization of Cough Stress Test
Primary Purpose
Stress Urinary Incontinence
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Cough Stress Test
Sponsored by
About this trial
This is an interventional diagnostic trial for Stress Urinary Incontinence focused on measuring cough stress test, urodynamics, pad test
Eligibility Criteria
Inclusion Criteria:
- symptoms of urinary incontinence as a chief complaint or as the reason for scheduling the clinic visit, and who were to be scheduled to undergo urodynamic (UDS) testing after initial evaluation by their physician
Exclusion Criteria:
- pelvic organ prolapse beyond stage 1 Pelvic Organ Prolapse- Quantification (POP-Q) as diagnosed by the examining physician
- any other clinical diagnosis other than urinary incontinence who undergo UDS testing ( e.g. interstitial cystitis, overactive bladder dry, bladder outlet obstruction)
- were taking alpha agonists or anticholinergic medications within 2 weeks of the testing
- had an elevated Post Void Residual (PVR) >50cc
- any physical or mental disability that would either not allow participation or impede the ability to give fully informed consent
- pregnancy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Experimental
Experimental
Arm Label
Group A
Group B
Group C
Group D
Arm Description
Cough Stress Test with a comfortably full bladder.
Cough Stress Test with an empty bladder after straight catheterization.
Cough Stress Test with a bladder infused with 200 cc of saline.
Cough Stress Test with the bladder filled to half functional capacity as determined from the largest voided volume recorded in the patient's voiding diary.
Outcomes
Primary Outcome Measures
Correlation of cough stress test with urodynamics
To define how different accepted cough stress test methods correlated with urodynamics in the evaluation of stress urinary incontinence.
Secondary Outcome Measures
24hour pad weight
To assess if there was any benefit to performing a 24 hour pad test with or without the different cough stress test modalities.
Full Information
NCT ID
NCT02742584
First Posted
April 14, 2016
Last Updated
April 19, 2016
Sponsor
University Hospitals Cleveland Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT02742584
Brief Title
Standardization of Cough Stress Test
Official Title
A Randomized Comparative Study Correlating Cough Stress Test With Urodynamics And 24 Hour Pad Test In the Evaluation of Stress Urinary Incontinence
Study Type
Interventional
2. Study Status
Record Verification Date
April 2016
Overall Recruitment Status
Completed
Study Start Date
August 2012 (undefined)
Primary Completion Date
March 2015 (Actual)
Study Completion Date
March 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospitals Cleveland Medical Center
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This is a multicenter, prospective, randomized comparative study in which patients are randomized to one of four different bladder volumes and a Cough Stress Test (CST) is performed in both the standing and sitting positions. The goal is to assess the agreement of each CST method with both urodynamics diagnosis of Stress Urinary Incontinence (SUI) and the 24-hour pad test. The primary outcome is to determine what CST method best correlated with either test in the diagnosis of SUI.
Detailed Description
This multicenter, prospective randomized study is approved by the Institutional Review Boards at both the University Hospitals Case Medical Center, Cleveland, OH, USA and MetroHealth Hospital, Cleveland, OH, USA (Identifiers 07-11-37 and FWA00003938, respectively). Adult women who presented to the Female Pelvic Medicine and Reconstructive Surgery (FPMRS) outpatient clinics at both the University Hospitals Case Medical Center and MetroHealth Hospital with symptoms of stress, urge, or mixed urinary incontinence and who were recommended by the evaluating staff to undergo urodynamic studies (UDS) are eligible. The staff physician will approach the patient for participation in this study after the standard clinic visit is completed and the initial diagnosis is made. A research coordinator will then explain the study and obtain informed consent if the patient agrees to participate. The patient will then be given instructions for a 24 hour pad test and standardized pads to use. The patient will also be given instructions for a three day voiding diary along with routine instruction regarding the urodynamic procedure. The patient will be asked to perform the 24 hour pad test the day prior to the UDS appointment. The three day voiding diary will be performed during a typical and sequential three day period during the week prior to the UDS. Patients will then asked to bring these items to the UDS appointment.
During the initial appointment with the study coordinator, patients will be randomized to 4 groups (A, B, C, and D). Patients in group A will be scheduled to undergo Cough Stress Test (CST) with a comfortably full bladder. This will be subjectively reported by the patient. Patients in group B will be scheduled to undergo CST with an empty bladder after straight catheterization. Group C patients will be scheduled to undergo CST with a bladder infused with 200 cc of saline. Patients in group D will be scheduled to undergo CST with the bladder filled to half functional capacity as determined from the largest voided volume recorded in the patient's voiding diary. CST will be performed in the standing and sitting position for each patient in each of the above groups. The sequence of performing the standing and sitting CST will be randomly assigned for each patient.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stress Urinary Incontinence
Keywords
cough stress test, urodynamics, pad test
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
140 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group A
Arm Type
Experimental
Arm Description
Cough Stress Test with a comfortably full bladder.
Arm Title
Group B
Arm Type
Experimental
Arm Description
Cough Stress Test with an empty bladder after straight catheterization.
Arm Title
Group C
Arm Type
Experimental
Arm Description
Cough Stress Test with a bladder infused with 200 cc of saline.
Arm Title
Group D
Arm Type
Experimental
Arm Description
Cough Stress Test with the bladder filled to half functional capacity as determined from the largest voided volume recorded in the patient's voiding diary.
Intervention Type
Procedure
Intervention Name(s)
Cough Stress Test
Intervention Description
Varying bladder volumes during cough stress test.
Primary Outcome Measure Information:
Title
Correlation of cough stress test with urodynamics
Description
To define how different accepted cough stress test methods correlated with urodynamics in the evaluation of stress urinary incontinence.
Time Frame
30 minutes
Secondary Outcome Measure Information:
Title
24hour pad weight
Description
To assess if there was any benefit to performing a 24 hour pad test with or without the different cough stress test modalities.
Time Frame
24 hours
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
symptoms of urinary incontinence as a chief complaint or as the reason for scheduling the clinic visit, and who were to be scheduled to undergo urodynamic (UDS) testing after initial evaluation by their physician
Exclusion Criteria:
pelvic organ prolapse beyond stage 1 Pelvic Organ Prolapse- Quantification (POP-Q) as diagnosed by the examining physician
any other clinical diagnosis other than urinary incontinence who undergo UDS testing ( e.g. interstitial cystitis, overactive bladder dry, bladder outlet obstruction)
were taking alpha agonists or anticholinergic medications within 2 weeks of the testing
had an elevated Post Void Residual (PVR) >50cc
any physical or mental disability that would either not allow participation or impede the ability to give fully informed consent
pregnancy
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Standardization of Cough Stress Test
We'll reach out to this number within 24 hrs